DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event

DNA Cell Biol. 2015 Nov;34(11):652-60. doi: 10.1089/dna.2015.2933. Epub 2015 Aug 26.

Abstract

The discovery of the process of small ubiquitin-like modifier (SUMO)-mediated post-translational modification of targets (SUMOylation) in early 1990s proved to be a significant step ahead in understanding mechanistic regulation of proteins and their functions in diverse life processes at the cellular level. The critical step in reversing the SUMOylation pathway is its ability to be dynamically deSUMOylated by SUMO/sentrin-specific protease (SENP). This review is intended to give a brief introduction about the process of SUMOylation, different mammalian deSUMOylating enzymes with special emphasis on their regulation of ribosome biogenesis at the molecular level, and its emerging roles in mitochondrial dynamics that might reveal usefulness of SENPs for therapeutic applications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Cycle / physiology
  • Cysteine Endopeptidases / genetics
  • Cysteine Endopeptidases / metabolism
  • Endopeptidases / genetics
  • Endopeptidases / metabolism*
  • Gene Expression Regulation
  • Humans
  • Mitochondria / genetics
  • Mitochondria / metabolism*
  • Molecular Targeted Therapy / methods*
  • Peptide Hydrolases / metabolism
  • Ribosomes / genetics
  • Ribosomes / metabolism*
  • Sumoylation*

Substances

  • Endopeptidases
  • Peptide Hydrolases
  • Cysteine Endopeptidases
  • SENP2 protein, human